We bring together innovators and investors to commercialise the companies that will form the longevity economy.
There are already 100+ rejuvenation biotechs working on unique therapies and building R&D pipelines to increase healthspan and lifespan.
At the same time, all around the world, innovators are releasing nanobots, reprogramming nerve signals and applying AI to create exciting and scalable contributions to human Longevity.
Longevity science is here; so are the risks and so are the rewards.
We look beyond rejuvenation therapies to embrace other technologies that participate in the Longevity investment category: Agetech, xeno, biomarkers, AI, bioprinting, neuroceuticals, GRAS supplements …
There are multiple technologies that contribute to the reduction of morbidity and the extension of lifespan.
Executive team
Phil Newman
Founder & CEO
Phil is a seasoned marketing and business development professional. He is also Editor-in-Chief of Longevity.Technology and oversees content strategy, market research, and deal-flow.
In his career, Phil has held c-level management positions across multiple tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.
George Sutherland
Non-exec Chairman
In over 30 years of experience in health markets, George has demonstrated many years of success working with major fast moving consumer goods (FMCG) and medical companies.
He as pre and post IPO experience, operating as a non-executive chairman for start-ups in health tech: First Longevity; Trueinvivo; TestCard.
Tom Britton
Non-exec Director
After completion of an MBA at Cambridge Tom co-founded SyndicateRoom – a data driven Venture Capital fund which has gone-on to be a leading platform in UK investment
His invaluable skills include: Early-stage Venture Finance, Product Development, Project / Program Management, Data Analysis, Process Implementation, and managing startups.
Advisory panel
Jim Mellon
Chairman & Founder,
Burnbrae Group, Juvenescence
Aubrey de Grey
Non-exec Chairman
George Church
Founding Core Faculty & Lead, Synthetic Biology, Harvard University
Greg Bailey
CEO
Juvenescence
Alexander Zhavoronkov
Chief Executive Officer Insilico Medicine, Inc
Lorraine Morley
UK Lead / Advisor,
AgeTech Accelerator
Michael Hufford
Co-Founder and CEO,
LyGenesis
João Pedro de Magalhães
Professor Institute of Ageing and Chronic Disease University of Liverpool
Team
Eleanor Garth
Deputy Editor
Danny Sullivan
Contributing Editor
Daragh Campbell
Head of Research
Dev Heaton
Marketing and Design Manager
Laura Allison
Marketing Executive
Harriet Grantham
Marketing Executive
Michael Hufford
Staff Writer
